February 1991
Volume 32, Issue 2
Free
Articles  |   February 1991
Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid.
Author Affiliations
  • G A Lutty
    Wilmer Ophthalmologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • K Ikeda
    Wilmer Ophthalmologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • C Chandler
    Wilmer Ophthalmologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • D S McLeod
    Wilmer Ophthalmologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Investigative Ophthalmology & Visual Science February 1991, Vol.32, 237-245. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G A Lutty, K Ikeda, C Chandler, D S McLeod; Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid.. Invest. Ophthalmol. Vis. Sci. 1991;32(2):237-245.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Retinal capillary closure is a common finding in many patients with diabetic retinopathy. The cause of this capillary occlusion is unknown. Since occlusions in microthromboembolic disease can occur because of deficiencies in tissue plasminogen activator (tPA) and since systemic tPA decreases with an increasing duration of diabetes mellitus, the immunohistochemical localization of tPA in the retinas and choroids of diabetic and nondiabetic patients was investigated. The localization of tPA was confined to arteries and arterioles in peripheral retinas from nondiabetics. Both veins and arteries were positive in these choroids. Two of three noninsulin-dependent diabetics had normal levels of immunoreactivity in their retinas, and all had normal levels of immunolocalization in their choroids. All but 2 of the 12 insulin-dependent diabetic eyes (IDDM), however, had reduced levels of retinal tPA immunoreactivity which was most pronounced in their peripheral retinas. Seven eyes from patients with IDDM had no reaction product in their peripheral retinas. Two such eyes also had reduced tPA immunoreactivity in their choroidal vessels. Some tPA-positive vessels were observed in the central retinas of these eyes, but the number of positive vessels and amount of reaction product was greatly reduced compared with eyes from nondiabetic patients. These observations suggest that IDDM patients have reduced fibrinolytic activity in their retinas, which might predispose them to thromboembolic disease.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×